Will NHC extend its 5.58% gain above 159.90 toward 161.80?

$National Healthcare(NHC)$

National Healthcare Corp(NHC) Jumps +5.58%: Reaching 52-Week High, Momentum Intact

Latest Close Data

On 2026-02-05 (ET), NHC closed at $159.90, up +5.58% (+$8.45). The stock hit its 52-week high of $161.80 during the session, closing just $1.90 below that peak.

Core Market Drivers

The rally appears to be driven by strong underlying financial performance, with a trailing EPS of $6.48 and solid ROE of 10.12%.
The stock also offers a dividend yield of 1.56%, attracting income-focused investors in the stable healthcare sector.

Technical Analysis

Volume was 77.5K shares with a Volume Ratio of 1.10, indicating slightly above-average participation.
The 6-day RSI is at a high 85.88, signaling overbought conditions and potential for a short-term pullback.
The MACD (DIF: 4.32, DEA: 2.65, MACD: 3.35) shows a strong and expanding bullish momentum.

Key Price Levels

Primary Support: $151.53 (Today's low and immediate pivot zone).
Strong Resistance: $161.80 (Today's high and 52-week high).
Immediate Pivot: ~$159.90 (Today's close). A break above $161.80 opens the door for further upside.

Valuation Perspective

The stock trades at a P/E (TTM) of 24.66x and a P/S (TTM) of 1.65x. This valuation is reasonable for a profitable healthcare services company with stable growth metrics.

Analyst Targets

Coverage is limited, with 1 analyst currently recommending a Buy. The lack of broad coverage suggests the stock may be under-followed by the institutional community.

Weekly Outlook

Expect consolidation or a minor pullback in the coming week as the RSI cools from overbought levels.
The key range is between $151.50 (support) and $161.80 (resistance).
A sustained break above $161.80 could target the $165+ area, while a break below $151.50 may see a test of the $145-147 zone.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.